News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
TANG KEVIN C
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/01/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Bought 347,932 shares
@ $1.05, valued at
$365.3k
Bought 200,000 shares
@ $1, valued at
$200k
Bought 32,890 shares
@ $1.06, valued at
$34.9k
Bought 2,016 shares
@ $1.08, valued at
$2.2k
Bought 5,930 shares
@ $1.06, valued at
$6.3k
Bought 161,180 shares
@ $1.08, valued at
$174.1k
Bought 5,000 shares
@ $1.1, valued at
$5.5k
Bought 92,984 shares
@ $1.09, valued at
$101.4k
Bought 240,341 shares
@ $1.12, valued at
$269.2k
|
|
| 06/01/2023 |
3
| TANG KEVIN C (10% Owner) has filed a Form 3 on Rain Oncology Inc. |
| 05/30/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Bought 50,000 shares
@ $1.72, valued at
$86k
|
|
| 05/15/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Bought 38,765 shares
@ $1.95, valued at
$75.6k
Bought 6,183 shares
@ $1.95, valued at
$12.1k
|
|
| 05/10/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Bought 57,073 shares
@ $1.95, valued at
$111.3k
Bought 20,141 shares
@ $1.95, valued at
$39.3k
Bought 6,774 shares
@ $1.95, valued at
$13.2k
|
|
| 05/05/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Bought 18,513 shares
@ $1.85, valued at
$34.2k
Bought 104,241 shares
@ $1.86, valued at
$193.9k
Bought 95,759 shares
@ $1.9, valued at
$181.9k
Bought 71,064 shares
@ $1.94, valued at
$137.9k
|
|
| 05/05/2023 |
3
| TANG KEVIN C (10% Owner) has filed a Form 3 on TCR2 THERAPEUTICS INC. |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Bought 65,701 shares
@ $0.994, valued at
$65.3k
Bought 20,286 shares
@ $1.018, valued at
$20.7k
|
|
| 03/14/2023 |
3
| TANG KEVIN C (10% Owner) has filed a Form 3 on Jounce Therapeutics, Inc. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/24/2022 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Unknown transaction of 9,607,934 shares
@ $6.23, valued at
$59.9M
Disposed/sold 18,000 options to buy
@ $9.2, valued at
$165.6k
Disposed/sold 10,000 options to buy
@ $19.69, valued at
$196.9k
Disposed/sold 10,000 options to buy
@ $28.24, valued at
$282.4k
Disposed/sold 10,000 options to buy
@ $19.19, valued at
$191.9k
Disposed/sold 10,000 options to buy
@ $28.1, valued at
$281k
Disposed/sold 12,000 options to buy
@ $5.99, valued at
$71.9k
Disposed/sold 12,000 options to buy
@ $3.93, valued at
$47.2k
Disposed/sold 30,000 options to buy
@ $4.53, valued at
$135.9k
Disposed/sold 30,000 options to buy
@ $4.81, valued at
$144.3k
Unknown transaction of 3,519 options to buy
@ $0 |
|
| 08/24/2022 |
4
| TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Unknown transaction of 9,607,934 shares
@ $6.23, valued at
$59.9M
Unknown transaction of 3,519 options to buy
@ $0 |
|
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/14/2022 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 12/01/2021 |
4
| TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Sold 193,403 shares
@ $4.1008, valued at
$793.1k
Sold 6,597 shares
@ $3.9514, valued at
$26.1k
Sold 63,745 shares
@ $3.9461, valued at
$251.5k
Sold 136,255 shares
@ $3.7586, valued at
$512.1k
Sold 41,290 shares
@ $3.6644, valued at
$151.3k
|
|
| 11/26/2021 |
4
| TANG KEVIN C (Exit Filing) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Sold 161,336 shares
@ $13.5216, valued at
$2.2M
Sold 124,509 shares
@ $12.4504, valued at
$1.6M
Sold 75,491 shares
@ $11.7422, valued at
$886.4k
Sold 149,111 shares
@ $11.1892, valued at
$1.7M
Sold 50,889 shares
@ $10.4279, valued at
$530.7k
Sold 200,000 shares
@ $10.0722, valued at
$2M
Sold 160,000 shares
@ $9.6035, valued at
$1.5M
|
|
| 11/22/2021 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Sold 43,213 shares
@ $9.3845, valued at
$405.5k
Sold 152,764 shares
@ $8.3234, valued at
$1.3M
Sold 4,023 shares
@ $8.0015, valued at
$32.2k
Sold 169,533 shares
@ $8.0947, valued at
$1.4M
Sold 30,467 shares
@ $8.0123, valued at
$244.1k
Sold 183,333 shares
@ $7.5205, valued at
$1.4M
Sold 16,667 shares
@ $7.3589, valued at
$122.7k
Sold 196,281 shares
@ $7.1081, valued at
$1.4M
Sold 3,719 shares
@ $6.6627, valued at
$24.8k
Sold 38,664 shares
@ $6.5532, valued at
$253.4k
|
|
| 11/19/2021 |
4
| TANG KEVIN C (CEO) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Sold 468,849 shares
@ $2.6583, valued at
$1.2M
Sold 31,151 shares
@ $1.9941, valued at
$62.1k
Sold 500,000 shares
@ $2.0161, valued at
$1M
Sold 287,577 shares
@ $2.1985, valued at
$632.2k
Sold 212,423 shares
@ $1.9708, valued at
$418.6k
Sold 500,000 shares
@ $1.8812, valued at
$940.6k
Sold 381,842 shares
@ $1.8925, valued at
$722.6k
Sold 365,289 shares
@ $1.9161, valued at
$699.9k
|
|
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 12/23/2020 |
4
| TANG KEVIN C (CEO) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Bought 62,144 shares
@ $14.5753, valued at
$905.8k
Bought 37,856 shares
@ $14.5754, valued at
$551.8k
Bought 36,646 shares
@ $15.1673, valued at
$555.8k
Bought 63,354 shares
@ $15.4282, valued at
$977.4k
Bought 75,784 shares
@ $15.708, valued at
$1.2M
|
|
| 11/16/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|
|
|